Convalescent Plasma to Treat COVID-19
Open Access
- 28 April 2020
- journal article
- editorial
- Published by American Medical Association (AMA) in JAMA
- Vol. 323 (16), 1561-1562
- https://doi.org/10.1001/jama.2020.4940
Abstract
In this issue of JAMA, Shen et al report findings from a preliminary study of 5 severely ill patients with coronavirus disease 2019 (COVID-19) who were treatedKeywords
This publication has 7 references indexed in Scilit:
- The convalescent sera option for containing COVID-19JCI Insight, 2020
- Characterization of Ebola convalescent plasma donor immune response and psoralen treated plasma in the United StatesTransfusion, 2020
- How do I … implement diagnostic management teams in transfusion medicine?Transfusion, 2019
- The Use of TKM-100802 and Convalescent Plasma in 2 Patients With Ebola Virus Disease in the United StatesClinical Infectious Diseases, 2015
- Convalescent transfusion for pandemic influenza: preparing blood banks for a new plasma product?Transfusion, 2010
- Use of convalescent plasma therapy in SARS patients in Hong KongEuropean Journal of Clinical Microbiology & Infectious Diseases, 2004
- The epidemiology of virus transmission by plasma derivatives: clinical studies verifying the lack of transmission of hepatitis B and C viruses and HIV type 1Transfusion, 1999